Progression anxiety in patients with brain tumors and their caregivers
- Conditions
- C71Malignant neoplasm of brain
- Registration Number
- DRKS00034637
- Lead Sponsor
- niversitätsklinikum Düsseldorf
- Brief Summary
ongitudinal study of fear of cancer progression, anxiety and depression of patients and their caregivers at all 3 time points (T0 = 3-7 days after diagnosis, T1 = 3 months after diagnosis, T2 = 6 months after diagnosis). In both groups, a considerable number of people reported clinically significant burden. Fear of cancer progression and anxiety remained consistent over time in patients and their caregivers, with depression scores increasing from T0 to T1. The caregivers reported higher anxiety at all time points and higher fear of cancer progression at T1 than the patients. Within the dyads of patients and caregivers, caregivers descriptively reported higher levels of burden more frequently than patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 142
legal capacity, further treatment at the neuro-oncology center of the UK Düsseldorf, C71 diagnosis, sufficient knowledge of German, participation of the patient together with the caregiver
Severe cognitive impairment
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fear of cancer progression (PAF-KF/PAF-KF-P)
- Secondary Outcome Measures
Name Time Method Anxiety (HADS-A), depression (HADS-D), distress (NCCN Distress Thermometer), quality of life (EORTC-QLQ-C30), sociodemographic and clinical characteristics